| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 137 |
| 1 | ASPIRIN 325 MG | 133 |
| 2 | ASPIRIN 81 MG | 133 |
| 3 | RIVAROXABAN | 90 |
| 4 | CLOPIDOGREL | 89 |
| 5 | CISPLATIN | 88 |
| 6 | BEVACIZUMAB | 78 |
| 7 | PREDNISONE | 77 |
| 8 | APIXABAN | 72 |
| 9 | PREDNISOLONE | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPTIFIBATIDE | 15 | 0.0194 |
| 1 | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | 1 | 0.0182 |
| 2 | UNDECYLENIC ACID | 2 | 0.0144 |
| 3 | ANGIOTENSIN II | 3 | 0.0100 |
| 4 | BENZNIDAZOLE | 1 | 0.0098 |
| 5 | BENZYL ALCOHOL | 1 | 0.0095 |
| 6 | CETRORELIX ACETATE | 5 | 0.0079 |
| 7 | TOLNAFTATE 1% | 2 | 0.0069 |
| 8 | HEPARIN SODIUM AND DEXTROSE | 4 | 0.0055 |
| 9 | ENALAPRILAT | 1 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 241 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 203 |
| 2 | Platinum-based Drug [EPC] | 184 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 150 |
| 4 | Factor Xa Inhibitor [EPC] | 120 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 115 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 85 |
| 7 | Kinase Inhibitor [EPC] | 72 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 67 |
| 9 | Loop Diuretic [EPC] | 65 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 3 | 0.0100 |
| 1 | Sclerosing Agent [EPC] | 3 | 0.0067 |
| 2 | Erythroid Maturation Agent [EPC] | 4 | 0.0015 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Anti-coagulant [EPC] | 5 | 0.0013 |
| 5 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 1 | 0.0013 |
| 6 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0013 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 18 | 0.0012 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 7 | 0.0011 |
| 9 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |